ARCHIVES

Phase III Custirsen/Docetaxel/Prednisone Trial Fails Primary Endpoint of Overall Survival

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

Home-Based Program Helps Older Cancer Survivors

May 29, 2009

Suit Against Craig Thompson Settled As Company He Co-Founded Licenses “Newly Identified” Discoveries From UPenn

September 14, 2012

FY09 Proposal for NIH Flat. NCI “Bypass Budget” Makes Case for $6 Billion.

February 8, 2008

2015: “A Challenge For Our Generation,” AACR Says

July 18, 2003

PIs On Both Sides of Screening Controversy Testified in Tobacco Trials.

October 26, 2007

Abstracts Of Papers From Conference On Adjuvant Therapy

April 22, 1977